BSE Live
Dec 31, 16:01Prev. Close
179.75
Open Price
179.80
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 31, 15:57Prev. Close
179.53
Open Price
180.00
Bid Price (Qty.)
180.29 (10)
Offer Price (Qty.)
0.00 (0)
| Balance Sheet of Marksans Pharma (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 45.32 | 45.32 | 45.32 | 40.93 | 40.93 | |
| Total Share Capital | 45.32 | 45.32 | 45.32 | 40.93 | 40.93 | |
| Reserves and Surplus | 1,338.17 | 1,177.39 | 1,066.01 | 743.74 | 558.79 | |
| Total Reserves and Surplus | 1,338.17 | 1,177.39 | 1,066.01 | 743.74 | 558.79 | |
| Total Shareholders Funds | 1,383.49 | 1,222.71 | 1,111.32 | 784.67 | 599.72 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax Liabilities [Net] | 12.15 | 9.41 | 8.64 | 9.01 | 8.49 | |
| Other Long Term Liabilities | 14.03 | 7.02 | 5.18 | 3.55 | 13.34 | |
| Long Term Provisions | 0.00 | 4.47 | 3.18 | 1.86 | 2.11 | |
| Total Non-Current Liabilities | 26.18 | 20.90 | 17.00 | 14.41 | 23.94 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 0.00 | 0.00 | 0.00 | 5.00 | 0.00 | |
| Trade Payables | 203.53 | 159.72 | 111.58 | 74.45 | 64.15 | |
| Other Current Liabilities | 142.10 | 110.77 | 103.64 | 86.35 | 29.78 | |
| Short Term Provisions | 0.00 | 1.96 | 1.33 | 0.72 | 0.97 | |
| Total Current Liabilities | 345.64 | 272.44 | 216.54 | 166.53 | 94.90 | |
| Total Capital And Liabilities | 1,755.30 | 1,516.04 | 1,344.86 | 965.61 | 718.55 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 380.90 | 268.51 | 140.88 | 131.86 | 124.84 | |
| Intangible Assets | 2.47 | 3.07 | 3.06 | 3.65 | 4.24 | |
| Capital Work-In-Progress | 0.00 | 0.00 | 3.91 | 0.00 | 0.00 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 383.37 | 271.58 | 147.85 | 135.51 | 129.09 | |
| Non-Current Investments | 265.75 | 265.75 | 265.75 | 236.07 | 236.07 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Non-Current Assets | 23.96 | 31.01 | 17.50 | 4.16 | 4.16 | |
| Total Non-Current Assets | 673.08 | 568.33 | 431.10 | 375.75 | 369.32 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.74 | 26.99 | 0.54 | 0.44 | 0.00 | |
| Inventories | 205.21 | 190.85 | 130.95 | 103.68 | 93.69 | |
| Trade Receivables | 549.58 | 370.17 | 305.49 | 246.78 | 146.79 | |
| Cash And Cash Equivalents | 268.69 | 312.23 | 440.26 | 224.05 | 105.71 | |
| Short Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| OtherCurrentAssets | 58.00 | 47.46 | 36.52 | 14.92 | 3.05 | |
| Total Current Assets | 1,082.22 | 947.70 | 913.76 | 589.86 | 349.24 | |
| Total Assets | 1,755.30 | 1,516.04 | 1,344.86 | 965.61 | 718.55 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 23.89 | 22.06 | 9.31 | 114.36 | 115.10 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 163.50 | 151.14 | 134.84 | 104.00 | 101.42 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | -- | -- | -- | -- | -- | |
| Other Earnings | 151.14 | 846.59 | 649.14 | 641.86 | 587.42 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | -- | -- | -- | -- | -- | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | 265.75 | 265.75 | 265.75 | 236.07 | 236.07 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | 0.74 | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | 26.99 | -- | -- | -- |
26.11.2025
Marksans Pharma Consolidated September 2025 Net Sales at Rs 720.41 crore, up 12.23% Y-o-Y
24.11.2025
Marksans Pharma Standalone September 2025 Net Sales at Rs 320.44 crore, up 3.83% Y-o-Y
09.09.2025
Marksans Pharma Standalone June 2025 Net Sales at Rs 319.73 crore, up 25.62% Y-o-Y
20.05.2025
Marksans Pharma Consolidated March 2025 Net Sales at Rs 708.46 crore, up 26.51% Y-o-Y